These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34133324)

  • 1. Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma.
    Sun X; Wang L; Li H; Jin C; Yu Y; Hou L; Liu X; Yu Y; Yan R; Xue F
    Aging (Albany NY); 2021 Jun; 13(12):16024-16042. PubMed ID: 34133324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
    Zhao HB; Zeng YR; Han ZD; Zhuo YJ; Liang YK; Hon CT; Wan S; Wu S; Dahl D; Zhong WD; Wu CL
    Cancer Sci; 2021 Oct; 112(10):4365-4376. PubMed ID: 34252262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
    Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
    Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment.
    Yao K; Wei L; Zhang J; Wang C; Wang C; Qin C; Li S
    Aging (Albany NY); 2020 Aug; 12(16):16238-16254. PubMed ID: 32833670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy.
    Zhang Q; Xia J; Wang Y; Zhang J; Ji C; Cong R; Wang Y; Song N
    Exp Cell Res; 2019 Nov; 384(1):111588. PubMed ID: 31473209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.
    Zheng Q; Peskoe SB; Ribas J; Rafiqi F; Kudrolli T; Meeker AK; De Marzo AM; Platz EA; Lupold SE
    Prostate; 2014 Dec; 74(16):1655-62. PubMed ID: 25252191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of stearoyl-coenzyme A desaturase in prostate adenocarcinoma: insights into gene expression, immune microenvironment and tumor progression.
    Wang J; Ying L; Xiong H; Zhou DR; Wang YX; Che HL; Zhong ZF; Wu GS; Ge YJ
    Front Immunol; 2024; 15():1460915. PubMed ID: 39351232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organization of data and tissue banks for new prognostic factors in adenocarcinoma of the prostate. An interdisciplinary uropathologic approach].
    Burger M; Hartmann A; Stoehr R; Hofstaedter F; Kneitz B; Riedmiller H; Wieland WF; Denzinger S
    Urologe A; 2007 Sep; 46(9):1094. PubMed ID: 17628773
    [No Abstract]   [Full Text] [Related]  

  • 10. Independent prognostic value of the 67-kd laminin receptor in human prostate cancer.
    Waltregny D; de Leval L; Ménard S; de Leval J; Castronovo V
    J Natl Cancer Inst; 1997 Aug; 89(16):1224-7. PubMed ID: 9274918
    [No Abstract]   [Full Text] [Related]  

  • 11. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of monoamine oxidase-A expression in high grade prostate cancer.
    Peehl DM; Coram M; Khine H; Reese S; Nolley R; Zhao H
    J Urol; 2008 Nov; 180(5):2206-11. PubMed ID: 18804811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
    Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
    Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.
    Xu C; Jung M; Burkhardt M; Stephan C; Schnorr D; Loening S; Jung K; Dietel M; Kristiansen G
    Prostate; 2005 Feb; 62(3):224-32. PubMed ID: 15389793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram.
    Hu M; Xie J; Liu Z; Wang X; Liu M; Wang J
    J Comput Biol; 2020 Dec; 27(12):1656-1667. PubMed ID: 32298604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy.
    Li X; Huang H; Zhang J; Jiang F; Guo Y; Shi Y; Guo Z; Ao L
    Prostate; 2020 Apr; 80(5):376-387. PubMed ID: 31961962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
    Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
    Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
    Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
    Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.